Indian firm to soon launch copycat of anti-breast-cancer drug.
.jpg)
The Companies Bill asked for promoting gender diversity by specifying induction of a minimum number of women directors
The policy proposes a contingency plan to handle cyber attacks on vital installations and critical infrastructure.
No respite in sight as not many big deals, initial public offerings in pipeline.
Despite slowdown, smaller firms attract growth capital.
Experts believe MNCs, which look for a strong foothold in the Indian kitchen appliances space, target the leading organised players in the industry.
In the latest initiative, the US food giant has roped in popular Indian cartoon character Chhota Bheem to sell various items through its retail outlets in India.
However, foreign investors have completely shunned the infrastructure sector.
PE firms are looking at various ways to protect their nominee directors.
Last week, Sun's Israeli subsidiary, Taro Pharma, received the US Food and Drug Administration's approval for its New Drug Application to launch Topicort Topical Spray for the treatment of psoriasis.
Compulsory licence application filed for anti-cancer drug of Bristol Myers Squibb; more to come for four drugs.
Brian Druker, who invented the drug's molecule, says it would benefit patients in the short term.
Patients' lobbies cheer ruling on anti-cancer drug Glivec, as affordability and access to life-saving drugs get a leg-up.
In some cases fake degrees and certificates were uncovered.
As funding from foreign private equity and venture capital firms is the lifeline for most online retailers, the restriction on foreign direct investment is threatening to block any fresh investment into the sector.
In 2012, drugs worth $35 billion went off-patent in the US, while the market size of drugs which will see patent expiry in 2013 will halve to $17 billion.
Past two years have witnessed a churn, mainly in the area of mergers and acquisitions.
The plan is to issue CLs for Trastuzumab (or Herceptin, used for treating breast cancer), Ixabepilone (used for chemotherapy in breast cancer treatment) and Dasatinib (or Sprycel, for leukaemia).
Sets up new financial services arm, Amit Goenka joins as CEO.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances